Metabolic response behind reduced cancer cell growth
2021-02-12
(Press-News.org) peer review/experimental study/animals/cells
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells' metabolism. These changes can be used as markers to discriminate whether a patient would respond to treatment by EZH2 inhibition. The study has been published in the journal Cell Death & Disease.
Multiple myeloma is a type of blood cancer where immune cells grow in an uncontrolled way in the bone marrow. The disease is very difficult to treat and is still considered incurable, and thus it is urgent to identify new therapeutic targets in the cancer cells.
The research group behind the new study has previously shown that cultivated multiple myeloma cells had reduced growth and were even killed if they were treated with a substance that inhibited the EZH2 protein. Now they found that EZH2 inhibition also reduced cancer growth in a multiple myeloma mouse model.
"We treated mice with a type of cancer that corresponds to human multiple myeloma with a substance that inhibits EZH2 and discovered several signs that the treated mice had slower cancer growth than non-treated mice. This provided further evidence for the potential of EZH2 as a target for clinical intervention," says Helena Jernberg Wiklund, professor at the Department of Immunology, Genetics and Pathology, who has led the study.
The results from the mouse model encouraged the researchers to further investigate what it is that makes the cells sensitive to EZH2 inhibition. Human multiple myeloma cells are more heterogeneous than mouse model cells and they found that some types of human cultivated multiple myeloma cells were sensitive whereas others were resistant.
To study this phenomenon further, the researchers employed a global analysis of cellular metabolites in combination with analysis of gene activity. Sensitivity was found to be associated with alterations in specific metabolic pathways in the cells.
"In cells that were sensitive to EZH2 inhibition, the methionine cycling pathways were altered, an effect we did not detect in non-sensitive cells. This alteration was caused by a downregulation of methionine cycling-associated genes," says Helena Jernberg Wiklund.
The alterations in metabolite abundance in the methionine cycling pathways could be used as markers to discriminate whether a patient is responding to EZH2 inhibition, which is of great importance for the potential clinical use of this treatment.
"Our findings provide an increased understanding of the mechanisms behind the sensitivity of multiple myeloma cells to EZH2 inhibition. They also highlight that global analysis of metabolites and gene activity are powerful tools and when used together, they provide a better understanding of what happens in cancer cells when exposed to novel treatments. We believe that our results are relevant to both preclinical and clinical researchers, as a step towards finding new ways to treat patients with multiple myeloma," says Helena Jernberg Wiklund.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-12
TROY, N.Y. -- An antioxidant found in green tea may increase levels of p53, a natural anti-cancer protein, known as the "guardian of the genome" for its ability to repair DNA damage or destroy cancerous cells. Published today in Nature Communications, a study of the direct interaction between p53 and the green tea compound, epigallocatechin gallate (EGCG), points to a new target for cancer drug discovery.
"Both p53 and EGCG molecules are extremely interesting. Mutations in p53 are found in over 50% of human cancer, while EGCG is the major anti-oxidant in green tea, a popular beverage worldwide," said END ...
2021-02-12
DURHAM, N.C. -- Humans aren't the only mammals that form long-term bonds with a single, special mate -- some bats, wolves, beavers, foxes and other animals do, too. But new research suggests the brain circuitry that makes love last in some species may not be the same in others.
The study, appearing Feb. 12 in the journal Scientific Reports, compares monogamous and promiscuous species within a closely related group of lemurs, distant primate cousins of humans from the island Madagascar.
Red-bellied lemurs and mongoose lemurs are among the few species in the lemur family tree in which male-female partners stick together year after year, working together to raise their young and defend their territory.
Once bonded, pairs spend much of their waking hours grooming ...
2021-02-12
Every year around 20 Australian children die from the incurable brain tumour, Diffuse Intrinsic Pontine Glioma (DIPG). The average age of diagnosis for DIPG is just seven years. There are no effective treatments, and almost all children die from the disease, usually within one year of diagnosis.
A paper published today 12 Feb 2021 in the prestigious journal, Nature Communications, reveals a potential revolutionary drug combination that - in animal studies and in world first 3D models of the tumour - is "spectacularly effective in eradicating the cancer cells," according to lead researcher and paediatric oncologist Associate Professor David Ziegler, from the Children's Cancer Institute and Sydney Children's Hospital.
In ...
2021-02-12
Children treated for cancer with approaches such as chemotherapy can develop therapy-related myeloid neoplasms (a second type of cancer) with a dismal prognosis. Scientists at St. Jude Children's Research Hospital have characterized the genomic abnormalities of 84 such myeloid neoplasms, with potential implications for early interventions to stop the disease. A paper detailing the work was published today in Nature Communications.
The somatic (cancer) and germline (inherited) genomic alterations that drive therapy-related myeloid neoplasms in children have not been comprehensively ...
2021-02-12
(Friday, February 12, 2021 - Toronto) -- Inhibiting a key enzyme that controls a large network of proteins important in cell division and growth paves the way for a new class of drugs that could stop glioblastoma, a deadly brain cancer, from growing.
Researchers at Princess Margaret Cancer Centre, the Hospital for Sick Children (SickKids) and University of Toronto, showed that chemically inhibiting the enzyme PRMT5 can suppress the growth of glioblastoma cells.
The inhibition of PRMT5 led to cell senescence, similar to what happens to cells during aging when cells lose the ability to divide and grow. Cellular senescence can also be a powerful tumour suppression mechanism, stopping ...
2021-02-12
Space: the final frontier. What's stopping us from exploring it? Well, lots of things, but one of the major issues is space radiation, and the effects it can have on astronaut health during long voyages. A new review in the open-access journal END ...
2021-02-12
Research over the last 20 years has shown that atherosclerosis is a chronic inflammatory condition of the arterial blood vessel wall. Soluble mediators such as cytokines and chemokines are pivotal players in this disease, promoting vascular inflammation. However, the development of anti-inflammatory therapeutics directed against such mediators that could prevent atherosclerosis has proven difficult, despite promising clinical studies in the recent past.
Previous anti-inflammatory therapeutic strategies to prevent atherosclerosis, heart attacks, strokes, rheumatoid arthritis and other inflammatory diseases have mainly been based ...
2021-02-12
Remote sensing technology has become a vital tool for scientists over the past several decades for monitoring changes in land use, ice cover, and vegetation across the globe. Satellite imagery, however, is typically available at only coarse resolutions, allowing only for the analysis of broad trends over large areas. Remote-controlled drones are an increasingly affordable alternative for researchers working at finer scales in ecology and agriculture, but the laser-based technology used to estimate plant productivity and biomass, such as light detection and ranging (LiDAR), remain prohibitively expensive.
In research presented in a recently published issue of Applications in Plant Sciences, researchers ...
2021-02-12
New research has shown that results of blood tests routinely performed by GPs everywhere contain a hidden fingerprint that can identify people silently developing potentially fatal liver cirrhosis.
The researchers have developed an algorithm to detect this fingerprint that could be freely installed on any clinical computer, making this a low-cost way for GPs to carry out large scale screening using patient data they already hold.
Liver cirrhosis is the second leading disease causing premature death in working-age people (after heart disease). It develops silently ...
2021-02-12
Peer-reviewed / Observational study / People
For the study, published in the journal Diabetes, Obesity and Metabolism, researchers analysed data from the UK Biobank of 500,000 people aged 58 years on average, and found that people with higher than normal blood sugar levels were 42% more likely to experience cognitive decline over an average of four years, and were 54% more likely to develop vascular dementia over an average of eight years (although absolute rates of both cognitive decline and dementia were low).
The associations remained true after other influential factors had been taken into account - including age, deprivation, smoking, BMI and whether or not participants had cardiovascular disease.
People with ...
LAST 30 PRESS RELEASES:
[Press-News.org] Metabolic response behind reduced cancer cell growth
